98%
921
2 minutes
20
Background: Evidence of any benefit in the long-term performance of highly crosslinked polyethylene (HXLPE) for total knee arthroplasty (TKA) is lacking. We sought to evaluate revision risk for HXLPE versus conventional polyethylene (CPE).
Methods: Data from a US-based health care system's Total Joint Replacement Registry were used to conduct a cohort study. Adult patients who underwent primary fixed-bearing TKA with patella resurfacing for osteoarthritis were included (2001 to 2023). The final study sample included 232,527 TKAs: 105,028 HXLPE and 127,499 CPE. The primary outcome was revision out to 20-year follow-up, and revision for any aseptic reasons as well as for wear and loosening were the secondary outcomes. Multivariable Cox regressions were used to evaluate revision risk by polyethylene with covariate adjustment.
Results: At 20-year follow-up, crude revision incidence was 6.0% for HXLPE and 6.1% for CPE. In adjusted analyses, a lower revision risk (hazard ratio [HR] = 0.93, 95% confidence interval [CI] = 0.88 to 0.98) was observed when comparing HXLPE with CPE. This lower risk was observed with other revision reasons evaluated (overall aseptic: HR = 0.93, 95% CI = 0.88 to 1.00; wear: HR = 0.75, 95% CI = 0.60 to 0.94; loosening: HR = 0.75, 95% CI = 0.67 to 0.84).
Conclusions: In this registry-based cohort study, 20-year revision incidence was approximately 6% regardless of polyethylene used. Still, we observed HXLPE to perform at least as well, if not better than CPE, at long-term follow-up in adjusted analyses, specifically for wear and loosening, supporting increased HXLPE use for TKA.
Level Of Evidence: Level III.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.arth.2025.07.005 | DOI Listing |
CNS Drugs
September 2025
Global Health Neurology Lab, Sydney, NSW, 2150, Australia.
Acute ischemic stroke (AIS) remains a leading cause of mortality and long-term disability globally, with survivors at high risk of recurrent stroke, cardiovascular events, and post-stroke dementia. Statins, while widely used for their lipid-lowering effects, also possess pleiotropic properties, including anti-inflammatory, endothelial-stabilizing, and neuroprotective actions, which may offer added benefit in AIS management. This article synthesizes emerging evidence on statins' dual mechanisms of action and evaluates their role in reducing recurrence, improving survival, and mitigating cognitive decline.
View Article and Find Full Text PDFDiabetologia
September 2025
Centre Universitaire de Diabétologie et de ses Complications, AP-HP, Hôpital Lariboisière, Paris, France.
Aims/hypothesis: Severe hypoglycaemia events (SHE) remain frequent in people with type 1 diabetes despite advanced diabetes technologies. We examined whether time below range (TBR) 3.9 mmol/l (70 mg/dl; TBR70) or 3.
View Article and Find Full Text PDFInn Med (Heidelb)
September 2025
Klink für Innere Medizin, Gastroenterologie und Diabetologie, Niels-Stensen-Kliniken Marienhospital Osnabrück, Osnabrück, Deutschland.
Helicobacter pylori was first characterized as an obligate bacterial pathogen in 1983. Since then, substantial advances have been made in understanding the pathophysiology of H. pylori infection, optimizing diagnostic and therapeutic strategies, and expanding testing and treatment-including in the prevention of gastric malignancies.
View Article and Find Full Text PDFJ Cancer Res Clin Oncol
September 2025
Cancer Treatment and Nuclear Cardiology Department, Al Azhar University, Cairo, Egypt.
Background: High-dose-rate (HDR) brachytherapy is essential in the treatment of locally advanced cervical cancer. While Iridium-192 (Ir-192) is commonly used, its short half-life imposes logistical and financial constraints, particularly in low- and middle-income countries (LMICs). Cobalt-60 (Co-60), with a longer half-life and lower operational costs, is a viable alternative.
View Article and Find Full Text PDFJ Am Acad Orthop Surg Glob Res Rev
September 2025
From the Mayo Clinic Alix School of Medicine, Scottsdale, AZ (Ms. Hiredesai and Mr. Holle), and the Department of Orthopedic Surgery, Mayo Clinic, Phoenix, AZ (Dr. Van Schuyver, Dr. Deckey, Dr. Probst, and Dr. Spangehl).
Atraumatic bilateral osteonecrosis of the femoral head (ONFH) is a rare phenomenon whose etiology is not fully understood. In this report, we describe the case of a 75-year-old female patient who developed rapidly onset bilateral ONFH after intra-articular corticosteroid injections. She was treated with staged bilateral total hip arthroplasty.
View Article and Find Full Text PDF